Assessing a novel immuno-oncology-based combination therapy: Ipilimumab plus electrochemotherapy
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Assessing a novel immuno-oncology-based combination therapy: Ipilimumab plus electrochemotherapy
Authors
Keywords
-
Journal
OncoImmunology
Volume 4, Issue 6, Pages e1008842
Publisher
Informa UK Limited
Online
2015-05-23
DOI
10.1080/2162402x.2015.1008842
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Electrochemotherapy for the management of melanoma skin metastasis: a review of the literature and possible combinations with immunotherapy
- (2014) Paola Queirolo et al. ARCHIVES OF DERMATOLOGICAL RESEARCH
- Immunological and biological changes during ipilimumab treatment and their potential correlation with clinical response and survival in patients with advanced melanoma
- (2014) Ester Simeone et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Efficacy and safety of ipilimumab in patients with advanced melanoma and brain metastases
- (2014) Paola Queirolo et al. JOURNAL OF NEURO-ONCOLOGY
- Clinical experience with ipilimumab 3 mg/kg: real-world efficacy and safety data from an expanded access programme cohort
- (2014) Paolo A Ascierto et al. Journal of Translational Medicine
- A Systemic Complete Response of Metastatic Melanoma to Local Radiation and Immunotherapy
- (2014) Susan M. Hiniker et al. Translational Oncology
- Electrochemotherapy with bleomycin induces hallmarks of immunogenic cell death in murine colon cancer cells
- (2014) Christophe Y Calvet et al. OncoImmunology
- Abscopal effects of radiotherapy on advanced melanoma patients who progressed after ipilimumab immunotherapy
- (2014) Antonio M Grimaldi et al. OncoImmunology
- Long-lasting response to electrochemotherapy in melanoma patients with cutaneous metastasis
- (2013) Corrado Caracò et al. BMC CANCER
- Patterns of onset and resolution of immune-related adverse events of special interest with ipilimumab
- (2013) Jeffrey S. Weber et al. CANCER
- Long-term survival and immunological parameters in metastatic melanoma patients who responded to ipilimumab 10 mg/kg within an expanded access programme
- (2013) Anna Maria Di Giacomo et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Efficacy and safety of ipilimumab 3mg/kg in patients with pretreated, metastatic, mucosal melanoma
- (2013) Michele Del Vecchio et al. EUROPEAN JOURNAL OF CANCER
- Use of Statins and the Risk of Death in Patients With Prostate Cancer
- (2013) Oriana Yu et al. JOURNAL OF CLINICAL ONCOLOGY
- Treatment of metastatic melanoma with electrochemotherapy
- (2013) Luca G. Campana et al. JOURNAL OF SURGICAL ONCOLOGY
- Nivolumab plus Ipilimumab in Advanced Melanoma
- (2013) Jedd D. Wolchok et al. NEW ENGLAND JOURNAL OF MEDICINE
- Electrochemotherapy for disseminated superficial metastases from malignant melanoma
- (2012) L. G. Campana et al. BRITISH JOURNAL OF SURGERY
- Dendritic cells recruitment in melanoma metastasis treated by electrochemotherapy
- (2012) Gianni Gerlini et al. CLINICAL & EXPERIMENTAL METASTASIS
- New Approaches to Melanoma Prevention
- (2012) June K. Robinson et al. DERMATOLOGIC CLINICS
- Antitumor effectiveness of electrochemotherapy: A systematic review and meta-analysis
- (2012) B. Mali et al. EJSO
- Ipilimumab and fotemustine in patients with advanced melanoma (NIBIT-M1): an open-label, single-arm phase 2 trial
- (2012) Anna Maria Di Giacomo et al. LANCET ONCOLOGY
- Immunologic Correlates of the Abscopal Effect in a Patient with Melanoma
- (2012) Michael A. Postow et al. NEW ENGLAND JOURNAL OF MEDICINE
- The confluence of radiotherapy and immunotherapy
- (2012) Byron Burnette et al. Frontiers in Oncology
- Management of cutaneous metastases using electrochemotherapy
- (2011) Louise Wichmann Matthiessen et al. ACTA ONCOLOGICA
- Ipilimumab: An Anti-CTLA-4 Antibody for Metastatic Melanoma
- (2011) E. J. Lipson et al. CLINICAL CANCER RESEARCH
- Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma
- (2011) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and safety of ipilimumab monotherapy in patients with pretreated advanced melanoma: a multicenter single-arm phase II study
- (2010) S. J. O'Day et al. ANNALS OF ONCOLOGY
- Single-institution experience with ipilimumab in advanced melanoma patients in the compassionate use setting
- (2010) Geoffrey Y. Ku et al. CANCER
- Ipilimumab experience in heavily pretreated patients with melanoma in an expanded access program at the University Hospital of Siena (Italy)
- (2010) Anna Maria Di Giacomo et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- A phase II multicenter study of ipilimumab with or without dacarbazine in chemotherapy-naïve patients with advanced melanoma
- (2010) Evan M. Hersh et al. INVESTIGATIONAL NEW DRUGS
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Guidelines for the Evaluation of Immune Therapy Activity in Solid Tumors: Immune-Related Response Criteria
- (2009) J. D. Wolchok et al. CLINICAL CANCER RESEARCH
- CTLA-4 blockade increases IFN -producing CD4+ICOShi cells to shift the ratio of effector to regulatory T cells in cancer patients
- (2008) C. I. Liakou et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now